Researchers at the University of Bath have developed a new technology that uses bacteria to build, chemically stabilize, and ...
Franzen wants to move DuPont from the materials sector, where it is considered a specialty chemicals company, to somewhere in ...
Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule modulatorsExpanded collaboration into Ono’s other priority ...
Seventy-two years after the first antipsychotic, Thorazine, was approved, psychiatry is now seriously discussing the need to ...
Chemists from St. Petersburg University has developed a new family of luminescent iridium complexes that, for the first time, realize a unique mechanism of photoactivated proton transfer. In the ...
A UC Santa Barbara research team has developed a technique for efficiently synthesizing non-natural amino acids and applying them to peptide construction.
Under the agreement, WuXi XDC will grant Earendil Labs an exclusive global license to its proprietary WuXiTecan-2 ...